Scientists said the results were 'off the charts' following ... lorlatinib to provide a new standard first-line treatment for patients with ALK-positive lung cancer. Debra Montague, chair or ...

General practitioners (GPs) may soon be able to identify patients with an increased risk of lung cancer up to four months ...

Samantha Murrell shares her journey with stage 4 NSCLC, a form of lung cancer. From her diagnosis to finding strength in treatment and support, she offers hopeful advice to others. New findings ...